Skip to main content
SpringerLink
Log in

Stable Modifications to the Expression of Neurohormones in the Rat Hypothalamus in a Model of Post-Traumatic Stress Disorder

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

We report studies of the neuroendocrine mechanisms of development of an anxiety state in rats using the “stress-restress” experimental model of post-traumatic stress disorder. Immunocytochemical methods demonstrated significant increases in corticoliberin expression in both the parvo- and magnocellular parts of the paraventricular nucleus persisting to 10 days after presentation of the animals with repeated stress. Decreases in vasopressin expression were seen in the paraventricular nucleus of the animals on the first day after repeated stress. Vasopressin contents in the parvocellular part of the nucleus in animals of the experimental group were no different at 10 days from those in animals of the control group, while levels in the magnocellular part were increased. These data provide evidence for the involvement of the hypothalamic component of the vasopressinergic system (along with the corticoliberinergic system) in the pathogenetic mechanisms of the analog of post-traumatic stress disorder generated in this model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. V. M. Voloshin, Post-Traumatic Stress Disorder. Phenomenology, Clinical Aspects Systematics, Dynamics, and Contemporary Approaches to Psychopharmacotherapy [in Russian], Anakharsis, Moscow (2005).

    Google Scholar 

  2. A. L. Pushkarev, V. A. Domoratskii, and E. G. Gordeeva, Post- Traumatic Stress Disorder: Diagnosis, Psychopharmacotherapy, Psychotherapy [in Russian], Institute of Psychotherapy Press, Moscow (2000).

    Google Scholar 

  3. M. V. Ugryumov, Mechanisms of Neuroendocrine Regulation [in Russian], Nauka, Moscow (1999).

    Google Scholar 

  4. V. G. Shalyapina, “Corticoliberin in the regulation of adaptive behavior in the pathogenesis of post-stress depression,” in: Basic Neuroendocrinology [in Russian], V. G. Shalyapina and P. D. Shabanov (eds.), ÉLBI, St. Petersburg (2005), pp. 84–146.

    Google Scholar 

  5. K.-B. Abel and J. A. Majzoub, “Molecular biology of the HPA axis,” in: Handbook of Stress and the Brain, T. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam (2005), pp. 79–95.

    Google Scholar 

  6. G. Aguilera and C. Rabadan-Deihl, “Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation,” Regul. Pept., 96, 23–29 (2000).

    Article  CAS  PubMed  Google Scholar 

  7. R. H. Belmaker and G. Agam, “Major depressive disorder: mechanisms of disease,” New. Engl. Med. J., 358, No. 1, 55–68 (2008).

    Article  CAS  Google Scholar 

  8. G. D. Bremner, I. Licono, and A. Darnell, “Elevated corticotropinreleasing factor concentration in posttraumatic stress disorders,” Am. J. Psychiatry, 154, No. 5, 624–629 (1997).

    CAS  PubMed  Google Scholar 

  9. C. S. de Kloet, E. Vermetten, E. Geuze, E. G. Lentjes, C. J. Heijnen, G. K. Stalla, and H. G. Westenberg, “Elevated plasma corticotrophin- releasing hormone levels in veterans with posttraumatic stress disorder,” Prog. Brain Res., 167, 287–291 (2007).

    Article  Google Scholar 

  10. C. S. De Kloet, E. Vermetten, C. J. Heijnen, E. Geuze, E. G. Lentjes, and H. G. Westenberg, “Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder,” Psychoneuroendocrinology, 32, No. 3, 215–226 (2007).

    Article  PubMed  Google Scholar 

  11. E. B. De Souza and D. E. Grigoriadis, “Corticotropin-releasing factor: physiology, pharmacology, and role in central nervous system disorders,” in: Neuropsychopharmacology: The Fifth Generation of Progress, K. L. Davis, J. T. Charney, J. T. Coyle, and C. Nemeroff (eds.), American College of Neuropsychopharmacology (2002), Chapter 7, pp. 91–107.

  12. A. J. Douglas, “Vasopressin and oxytocin,” in: Handbook of Stress and the Brain. Part 1. The Neurobiology of Stress, N. H. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam, etc. (2005), pp. 205–230.

    Google Scholar 

  13. B. H. Harvey, C. Naciti, L. Brand, and D. J. Stein, “Endocrine, cognitive and hippocampal/cortical 5HT1A/2A receptor changes evoked by a time-dependent sensitisation (IDS) stress model in rats,” Brain Res., 983, 97–107 (2003).

    Article  CAS  PubMed  Google Scholar 

  14. F. Holsboer, “Corticotropin-releasing hormone modulators and depression,” Curr. Opin. Investig. Drugs, 4, 46–50 (2003).

    CAS  PubMed  Google Scholar 

  15. F. Holsboer, “Neuroendocrinology of mood disorders,” in: Psychopharmacology: the Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer (eds.), Raven Press, New York (1995), Chapter 83, pp. 957–970.

    Google Scholar 

  16. J. W. Kaskow, D. Baker, and T. D. Geracioti, “Corticotropin-releasing hormone in depression and post-traumatic stress disorder,” Peptides, 22, 845–851 (2001).

    Article  Google Scholar 

  17. I. Liberzon, M. Krstov, and E. A. Young, “Stress-restress: effects on ACTH and fast feedback,” Psychoneuroendocrinology, 26, 443–453 (1997).

    Article  Google Scholar 

  18. M. Olff, Y. Güzelcan, G. J. De Vries, J. Assies, and B. P. Gersons, “HPA- and HPT-axis alterations in chronic posttraumatic stress disorder,” Psychoneuroendocrinology, 31, No. 10, 1220–1230 (2006).

    Article  CAS  PubMed  Google Scholar 

  19. M. A. Oquendo, G. Echavarria, H. C. Galfalvy, M. F. Grunebaum, I. Burke, A. Barrera, T. B. Cooper, K. M. Malone, and J. J. Mann, “Lower cortisol levels in depressed patients with comorbid posttraumatic stress disorder,” Neuropsychopharmacology, 28, 591–598 (2003).

    Article  CAS  PubMed  Google Scholar 

  20. M. Owens and C. B. Nemeroff, “Physiology and pharmacology of corticotropin-releasing factor,” Pharmacol. Rev., 43, No. 4, 425–473 (1991).

    CAS  PubMed  Google Scholar 

  21. P. H. Rosebloom, N. H. Kalin, T. Steckler, and F. M. Dautzenberg, “Molecular regulation of the CRF system,” in: Handbook of Stress and the Brain. Part 1. The Neurobiology of Stress, T. Steckler, N. H. Kalin, and J. M. H. M. Reul (eds.), Elsevier, Amsterdam, etc. (2005), Vol. 15, pp. 133–152.

    Google Scholar 

  22. L. Scott and T. G. Dinan, “Vasopressin as a target for antidepressant development: an assessment of available evidence,” J. Affect. Disord., 72, 113–124 (2002).

    Article  CAS  PubMed  Google Scholar 

  23. D. Simeon, M. Knutelska, R. Yehuda, F. Putnam, J. Schmeidler, and L. M. Smith, “Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers,” Biol. Psychiatry, 61, No. 8, 966–973 (2007).

    Article  CAS  PubMed  Google Scholar 

  24. G. N. Smagin, S. C. Heinrics, and A. J. Dunn, “The role of CRH in behavioral responses to stress,” Peptides, 22, 713–724 (2001).

    Article  CAS  PubMed  Google Scholar 

  25. J. D. K. Uys, D. J. Stein,W. M. U. Daniels, and B. H. Harvey, “Animal models of anxiety disorders,” Curr. Psychiat. Rep., 5, 274–281 (2003).

    Article  Google Scholar 

  26. L. Weisaeth, “Vulnerability and protective factors for posttraumatic stress disorder,” Psychiat. Clin. Neurosci., 52, No. 5, 83–88 (1998).

    Article  Google Scholar 

  27. R. Yehuda, “Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications,” Ann. N.Y. Acad. Sci., 1071, 137–156 (2006).

    Article  CAS  PubMed  Google Scholar 

  28. R. Yehuda and S. M. Antelman, “Criteria for evaluating animal models of post traumatic stress disorder,” Biol. Psychiat., 33, 479–486 (1993).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. P. Pavlov Institute of Physiology, Russian Academy of Sciences, 6 Makarov Bank, 199034, St. Petersburg, Russia

    V. I. Mironova & E. A. Rybnikova

Authors
  1. V. I. Mironova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. A. Rybnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. I. Mironova.

Additional information

Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 94, No. 11, pp. 1277–1284, November, 2008.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mironova, V.I., Rybnikova, E.A. Stable Modifications to the Expression of Neurohormones in the Rat Hypothalamus in a Model of Post-Traumatic Stress Disorder. Neurosci Behav Physi 40, 111–115 (2010). https://doi.org/10.1007/s11055-009-9216-5

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-009-9216-5

Key words

Search

Navigation